Package 62135-122-30

Brand: ondansetron

Generic: ondansetron
NDC Package

Package Facts

Identity

Package NDC 62135-122-30
Digits Only 6213512230
Product NDC 62135-122
Product ID 62135-122_1ba47f65-782d-bcae-e063-6294a90a39a5
Description

30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-122-30)

Marketing

Marketing Status
Marketed Since 2022-03-30
Brand ondansetron
Generic ondansetron
Sample Package No

Linked Drug Pages (1)

Ondansetron ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1ba47f65-782d-bcae-e063-6294a90a39a5", "openfda": {"nui": ["N0000175817", "N0000175818"], "upc": ["0362135879303", "0362135121303", "0362135878306", "0362135122300"], "unii": ["4AF302ESOS"], "rxcui": ["104894", "312087", "2685489", "2685613"], "spl_set_id": ["4c74336c-11ec-420a-80e1-d8e4a8f1c46d"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-122-30)", "package_ndc": "62135-122-30", "marketing_start_date": "20220330"}], "brand_name": "Ondansetron", "product_id": "62135-122_1ba47f65-782d-bcae-e063-6294a90a39a5", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "62135-122", "generic_name": "Ondansetron", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON", "strength": "8 mg/1"}], "application_number": "ANDA077406", "marketing_category": "ANDA", "marketing_start_date": "20061226", "listing_expiration_date": "20261231"}